相关实验视频

Updated: Jun 3, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

基于使用机器学习方法的临床数据,对卵巢癌的早期预测和风险分层

Ting Gui¹, Dongyan Cao¹, Jiaxin Yang¹

¹Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric and Gynecologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Journal of gynecologic oncology

|January 10, 2025

概括

这项研究开发了一种用于早期卵巢癌诊断的机器学习模型. 该模型使用实验室和成像数据,可以比传统的病理学检查早大约17天预测卵巢癌.

科学领域:

在瘤学瘤学.
医疗信息学医疗信息学
医疗保健中的机器学习

背景情况:

卵巢癌的诊断通常依赖于晚期检测.
提前诊断时间表对于改善患者结果至关重要.

研究的目的:

构建用于早期卵巢癌诊断的机器学习模型.
为了确定卵巢癌的关键预测特征.

主要方法:

对9799名患有骨盆/尾/卵巢质量患者的回顾性分析.
使用5倍交叉验证进行特征选择和模型优化.
使用Shapley添加式解释 (Shap) 方法识别顶级预测特征.

主要成果:

在预测卵巢癌方面,LightGBM算法实现了88%的准确性.
最重要的特征包括实验室测试 (55%),成像 (35%) 和人口统计/症状 (10%).
该模型在病理检查前大约17天推进了卵巢癌诊断.

结论:

轻GBM是一个有效的算法用于卵巢癌预测.
实验室检测和成像对于早期诊断至关重要.
开发的模型显著推进了卵巢癌的诊断时间表.

关键词:

机器学习机器学习机器预测方法机器预测方法卵巢癌卵巢癌卵巢癌预测性学习模型预测性学习模型风险因素风险因素

更多相关视频

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...